Figure 1
Figure 2
Figure 3
Figure 4
Patients’ and treatment characteristics
| Age (median) | 73 years |
| (SD) | 3.7 years |
| Gender | |
| Female | 99 (47.8%) |
| Male | 108 (52.2%) |
| Surgery | |
| No | 5 (2.5%) |
| Biopsy | 69 (33.3%) |
| Reduction | 96 (46.4%) |
| Gross total resection | 37 (17.9%) |
| Performance status WHO | |
| 0 | 3 (1.5%) |
| I | 53 (25.6%) |
| II | 65 (31.4%) |
| III | 70 (33.8%) |
| IV | 16 (7.7%) |
| Radiotherapy | 158 (76.3%) |
| > 50 Gy | 57 (27.5%) |
| 40-50 Gy | 33 (15.9%) |
| ≤ 40 Gy | 68 (32.8%) |
| Temozolomide | 62 (30.0%) |